牛牛AI助理已提取核心訊息
Omar Jimenez, a director and 10% owner of 180 Life Sciences Corp, has filed an Initial Statement of Beneficial Ownership of Securities with the SEC, as per Form 3 requirements. The filing, dated March 7, 2024, indicates that no securities are beneficially owned by Jimenez. The form, signed on March 11, 2024, is a standard disclosure for individuals in significant positions within publicly traded companies, and it is used to report any direct or indirect ownership of the company's securities. This filing is part of the regulatory compliance under Section 16(a) of the Securities Exchange Act of 1934.
Omar Jimenez, a director and 10% owner of 180 Life Sciences Corp, has filed an Initial Statement of Beneficial Ownership of Securities with the SEC, as per Form 3 requirements. The filing, dated March 7, 2024, indicates that no securities are beneficially owned by Jimenez. The form, signed on March 11, 2024, is a standard disclosure for individuals in significant positions within publicly traded companies, and it is used to report any direct or indirect ownership of the company's securities. This filing is part of the regulatory compliance under Section 16(a) of the Securities Exchange Act of 1934.
根據表格3的要求，180生命科學公司的董事兼10％所有者奧馬爾·希門尼斯已向美國證券交易委員會提交了初步的證券實益擁有權聲明。這份日期爲2024年3月7日的文件表明，希門尼斯沒有實益持有任何證券。該表格於2024年3月11日簽署，是公開交易公司中擔任重要職位的個人的標準披露聲明，用於報告公司證券的任何直接或間接所有權。該文件是1934年《證券交易法》第16（a）條規定的監管合規的一部分。
根據表格3的要求，180生命科學公司的董事兼10％所有者奧馬爾·希門尼斯已向美國證券交易委員會提交了初步的證券實益擁有權聲明。這份日期爲2024年3月7日的文件表明，希門尼斯沒有實益持有任何證券。該表格於2024年3月11日簽署，是公開交易公司中擔任重要職位的個人的標準披露聲明，用於報告公司證券的任何直接或間接所有權。該文件是1934年《證券交易法》第16（a）條規定的監管合規的一部分。
有用
沒用